Edition:
United Kingdom

Abeona Therapeutics Inc (ABEO.OQ)

ABEO.OQ on NASDAQ Stock Exchange Capital Market

8.12USD
5:05pm BST
Change (% chg)

$0.13 (+1.63%)
Prev Close
$7.99
Open
$8.02
Day's High
$8.19
Day's Low
$7.85
Volume
53,904
Avg. Vol
163,324
52-wk High
$22.00
52-wk Low
$6.28

About

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel gene therapies for life-threatening rare genetic diseases. The Company’s lead programs include ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and EB-101 (gene-corrected skin... (more)

Overall

Beta: 1.92
Market Cap(Mil.): $384.26
Shares Outstanding(Mil.): 48.09
Dividend: --
Yield (%): --

Financials

  ABEO.OQ Industry Sector
P/E (TTM): -- 110.59 62.94
EPS (TTM): -1.19 -- --
ROI: -34.64 8.01 11.75
ROE: -37.27 8.19 12.58

Earnings vs. Estimates